Literature DB >> 1970703

Detection of molecular rearrangements in Prader-Willi syndrome patients by using genomic probes recognizing four loci within the PWCR.

C A Gregory1, A J Kirkilionis, C R Greenberg, A E Chudley, J L Hamerton.   

Abstract

The Prader-Willi chromosome region (PWCR) in Prader-Willi syndrome patients was analyzed by using genomic DNA probes mapping to 15q11.2-q12. The present report includes analysis of dosage by RFLP and densitometric studies, and analysis of restriction patterns. Twelve Prader-Willi syndrome (PWS) patients were studied: 5 had deletions of 15q11-q13, one had an unbalanced translocation, and 6 were karyotypically normal. Four genomic DNA probes were used: pML34 (D15S9); pTD3-21 (D15S10); IR4-3 (D15S11), a subclone of IR4; and IR10-1 (D15S12), a subclone of IR10 (Donolon et al.: Proc Natl Acad Sci USA 83:4408-4412, 1986). The results presented demonstrate that molecular rearrangements have occurred in 10 of the 12 PWS patients investigated and that the specific rearrangements differ from patient to patient. Patients with apparently similar cytogenetic deletions differ at the molecular level with deletions and/or duplications of various loci. The present study reports molecular alterations within the PWCR in PWS patients reported as cytogenetically normal. However, the 6 karyotypically normal patients are a heterogeneous group with molecular rearrangements ranging from none detected to deletions and/or duplications. These molecular studies suggest that a physical disruption of the PWCR causes the PWS not only in those patients reported to have a cytogenetic aberration but also in those identified as apparently karyotypically normal. The question remains as to whether the PWS patients in whom a molecular abnormality has not been detected have an autosomal recessive form of PWS, a molecular disruption which has not yet been detected, or another mechanism producing an apparently identical phenotype. The order of the 4 loci on chromosome 15 is hypothesized to be cen----D15S9----D15S12----D15S11----D15S10.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970703     DOI: 10.1002/ajmg.1320350420

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  RFLPs are detected by two probes isolated by chromosome walking from pTD3-21 (D15S10) which maps to 15q11.2-12.

Authors:  C A Gregory; J S Schwartz
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

2.  Molecular, cytogenetic, and clinical investigations of Prader-Willi syndrome patients.

Authors:  W P Robinson; A Bottani; Y G Xie; J Balakrishman; F Binkert; M Mächler; A Prader; A Schinzel
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

3.  Somatic recombination rather than uniparental disomy suggested as another mechanism by which genetic imprinting may play a role in the etiology of Prader-Willi syndrome.

Authors:  C A Gregory; J Schwartz; A J Kirkilionis; N Rudd; J L Hamerton
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

4.  Molecular and cytogenetic studies of the Prader-Willi syndrome.

Authors:  R J Trent; F Volpato; A Smith; R Lindeman; M K Wong; G Warne; E Haan
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

5.  Molecular study of chromosome 15 in 22 patients with Angelman syndrome.

Authors:  J Beuten; K Mangelschots; I Buntinx; P Coucke; O F Brouwer; R C Hennekam; C Van Broeckhoven; P J Willems
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

6.  A de novo unbalanced reciprocal translocation identified as paternal in origin in the Prader-Willi syndrome.

Authors:  A Smith; R Lindeman; F Volpato; A Kearney; S White; E Haan; R J Trent
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

7.  Interstitial deletions in DiGeorge syndrome detected with microclones from 22q11.

Authors:  A H Carey; U Claussen; H J Lüdecke; B Horsthemke; D Ellis; H Oakey; D Wilson; J Burn; R Williamson; P J Scambler
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.